In addition, the authors demonstrated that Bmi-1 confers resistance to apoptosis in glioma cells via the IKK-NF-kB pathway, suggesting that this is a useful prognostic marker for gliomas. The gene discussed is NFKB1; the disease is central nervous system cancer.